Ramesh Rengan, MD, discusses the strengths and limitations of proton beam radiotherapy for the management of solid tumors and the value of toxicity mitigation as a strategy to improve clinical outcome in solid tumors.
Related Presenters
Medical Director, SCCA Proton Therapy
Dr. Rengan is internationally known for his work in treating patients with lung cancer, esophageal cancer, thoracic malignancies, and melanoma. He also specializes in genitourinary tumors including prostate cancer. Dr. Rengan is the medical ...
Related Videos
